host specificity. There thus is little danger that a laboratory worker could be infected (15 ). However, proper clinical laboratory safety precautions should be followed because the phage IACs represent genetically modified organisms. The presented protocol to generate phage IAC could be applied to any clinical PCR assay in which DNA from pathogens is detected. When phage IACs are added to clinical specimens before DNA extraction, all steps of the PCR assay, including lysis of pathogen particles, can be controlled.
. Trp is the substrate for the first step in both of these pathways. In the Kyn pathway, the indole ring of Trp can be opened by the enzymes tryptophan pyrrolase [tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase (IDO)] (3 ). The reactions catalyzed by both of these enzymes constitute the rate-limiting step in the Kyn metabolic pathway (4 ) . The organ distribution of the two enzymes differs, allowing them to be clearly distinguished (5, 6 ) . Tryptophan 2,3-dioxygenase is located primarily in the liver, and its activity is up-regulated in response to Trp and metabolic steroids. IDO can be found in various cells, but it is not active in healthy humans and its activity is induced only during immune responses mediated by proinflammatory cytokines such interferon-␥ (7, 8 ) .
The enzymatic reactions of the Kyn pathway produce NAD and other intermediates, including Kyn and quinolinic acid (5, 9 ) . The removal of Trp from the microenvironment via this pathway protects the organism by limiting the growth of intracellular pathogens and malignant cells and may also prevent maternal immune reactions against the fetus during pregnancy (10 -14 ) . The Kyn-toTrp ratio provides an estimate of IDO activity that is independent of baseline Trp concentrations (15) (16) (17) . In plasma, Kyn/Trp may be correlated with the concentrations of inflammatory markers, such as neopterin, to ensure that Trp degradation is induced by interferon-␥ and involves IDO (18 ) . Kyn/Trp is higher in individuals with diseases that involve an activated cellular immune response or those undergoing cytokine immunotherapy (16, 17, 19 ) .
Here we describe a procedure for the determination of Kyn and Trp concentrations in human plasma or in supernatants of human cell cultures. This method involves HPLC coupled to coulometric detection.
l-Kyn and l-Trp were purchased from Sigma. We obtained potassium dihydrogen phosphate (KH 2 PO 4 ) and sodium monohydrogen phosphate (Na 2 HPO 4 ) from Prolabo. Acetonitrile, perchloric acid (HClO 4 ), and l-ascorbic acid were from Merck. The mobile phase was a 94:6 mixture (by volume) of 16.2 mmol/L KH 2 PO 4 and acetonitrile. The mobile phase was used at ambient temperature at a flow rate of 0.9 mL/min.
Chromatography was performed with a Thermofinnigan solvent delivery SpectraSeries P100 pump. Samples were vortex-mixed and centrifuged at 12 000g for 5 min. We then mixed 50 L of the supernatant with 250 L of 0.1 mol/L Na 2 HPO 4 in a microsampling vial to buffer the sample after acid precipitation of the proteins. We injected 50 L of the resulting mixture into the HPLC system. We used the same method to generate calibration curves with Trp and Kyn calibration solutions. Individual stock solutions of Trp and Kyn were prepared in methanol and stored at Ϫ80°C for a maximum of 3 months. Immediately before each HPLC analysis, these stock solutions were used to prepare a calibration mixture containing Trp and Kyn. Calibration curves were constructed with seven concentrations of the two compounds, including a zero point. The concentrations were calculated from peak heights. Retention times were 6.8 min for Kyn and 11.6 min for Trp (Fig. 1A) . It was not necessary to replace the precolumn or the analytical cell during the 4-month study period, during which ϳ3000 specimens were analyzed.
We used a pool of EDTA-plasma samples from healthy blood donors, aliquoted into 10 samples, for evaluating the stability of Trp and Kyn on 3 consecutive days. Between analyses, samples were stored protected from light at 4°C. The CVs were 2.3% and 1.3% for mean (SD) Trp concentrations of 73.2 (1.7) mol/L (day 2; n ϭ 10) and 72.1 (0.9) mol/L (day 3; n ϭ 10), respectively. The CVs were 2.0% and 1.2% for Kyn concentrations of 2.4 (0.05) mol/L (day 1; n ϭ 10) and 2.5 (0.03) mol/L (day 2; n ϭ 10), respectively. We evaluated the stability of these compounds over 24 h in Na 2 HPO4, stored in microsampling vials protected from light at 4°C. The CVs were 3.6% and 3.1% for a Trp concentration of 70.4 (2.51) mol/L (n ϭ 10) and a Kyn concentration of 2.7 (0.08) mol/L (n ϭ 10), respectively. Stability during storage in microsampling vials was therefore satisfactory for up to 24 h at 4°C. We also tested the reproducibility of this method over 20 consecutive days. For this purpose, two pools of plasma samples were each aliquoted into 20 samples and stored at Ϫ20°C. Each day, one sample from each pool was assessed in duplicate. The between-day variations were 4. (20, 21 ) .
The main advantage of our method lies in the use of a coulometric detection system, which is devoid of the quenching problems associated with fluorescence detection and provides high specificity. In contrast to the methods of Laich et al. (21 ) and Vaarmann et al. (22 ) , we used only one detector with one analytical cell. The choice of 0.06 mmol/L ascorbic acid is important. When the ascorbic acid concentration was high (0.6 mmol/L), Trp concentrations in samples left for 8 h at ambient temperature increased by 25%, and when no ascorbic acid was added, the observed Kyn concentrations were threefold lower.
Trp and Kyn concentrations were determined in the supernatants from cultures of human primary macrophages in serum-free medium with this HPLC method (Fig. 1B) . Between-day reproducibility was assessed on the supernatants of macrophages, which contained Trp and were supplemented with Kyn and aliquoted into 20 samples. We analyzed one sample per day for 20 days. The CV were 4.7% for a Trp concentration of 42.6 (2.0) mol/L and 7.6% for a Kyn concentration of 0.73 (0.06) mol/L. The lowest quantifiable concentrations of Trp and Kyn determined in supernatants of cell cultures with this HPLC method were similar to those for plasma.
